Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy.

Front Immunol · 2020 · PMC7878378 · PMID 33584658

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

narrowly missed significanceno p-value reported

Soluble CD62P demonstrated a similar pattern, although the difference between participants on cART who used tobacco and cART-naïve non-users narrowly missed significance.

also in 112 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.